[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023[J].CA Cancer J Clin,2023,73(1):17-48.
[3] WILLIAMSON SR,TANEJA K,CHENG L.Renal cell carcinoma staging:pitfalls,challenges,and updates[J].Histopathology,2019,74(1):18-30.
[4] SUNG H,SIEGEL RL,TORRE LA,et al.Global patterns in excess body weight and the associated cancer burden[J].CA Cancer J Clin,2019,69(2):88-112.
[5] 施旭,冯德超,李登雄,等.代谢综合征和肾癌的研究进展[J].临床泌尿外科杂志,2022,37(9):712-717.
SHI X,FENG DC,LI DX,et al.Research progress of metabolic syndrome and renal cancer[J].Journal of Clinical Urology,2022,37(9):712-717.
[6] FATEH SM,ARKAWAZI LA,TAHIR SH,et al.Renal cell carcinoma T staging:Diagnostic accuracy of preoperative contrast-enhanced computed tomography[J].Mol Clin Oncol,2023,18(2):11.
[7] ZENG Q,WANG L,DONG SY,et al.CT-derived abdominal adiposity:Distributions and better predictive ability than BMI in a nationwide study of 59 429 adults in China[J].Metabolism,2021,115:154456.
[8] NGUYEN GK,MELLNICK VM,YIM AK,et al.Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with renal cell carcinoma[J].Radiology,2018,287(3):884-892.
[9] PARKER WP,CHEVILLE JC,FRANK I,et al.Application of the stage,size,grade,and necrosis (SSIGN) score for clear cell renal cell carcinoma in contemporary patients[J].Eur Urol,2017,71(4):665-673.
[10] HAN D,YU Y,HE T,et al.Effect of radiomics from different virtual monochromatic images in dual-energy spectral CT on the WHO/ISUP classification of clear cell renal cell carcinoma[J].Clin Radiol,2021,76(8):627.e23-627.e29.
[11] 高杨,陈炜越,陈春妙,等.肾透明细胞癌的CT特征与其侵袭性的相关性研究[J].中国中西医结合影像学杂志,2022,20(3):250-254,258.
GAO Y,CHEN WY,CHEN CM,et al.CT features of clear cell renal cell carcinoma and its correlation with the invasiveness[J].Chinese Imaging Journal of Integrated Traditional and Western Medicine,2022,20(3):250-254,258.
[12] BUDNY A,GROCHOWSKI C,KOZLOWSKI P,et al.Obesity as a tumour development triggering factor[J].Ann Agric Environ Med,2019,26(1):13-23.
[13] STEFAN N.Causes,consequences,and treatment of metabolically unhealthy fat distribution[J].Lancet Diabetes Endocrinol,2020,8(7):616-627.
[14] EBADI M,MAZURAK VC.Evidence and mechanisms of fat depletion in cancer[J].Nutrients,2014,6(11):5280-5297.
[15] KANEKO G,MIYAJIMA A,YUGE K,et al.Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma[J].Jpn J Clin Oncol,2015,45(2):210-216.
[16] 翁同辉,任轲,陈晗,等.内脏脂肪面积与肾癌病理分型及分级的相关性[J].现代泌尿外科杂志,2021,26(4):322-327.
WENG TH,REN K,CHEN H,et al.Correlation between visceral fat area with the pathological type and grade in renal cell carcinoma[J].Journal of Modern Urology,2021,26(4):322-327.
[17] HU ZX,WU JL,LAI SS,et al.Clear cell renal cell carcinoma:the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade[J].Eur Radiol,2020,30(7):3977-3986.
[18] SANTONI M,CIMADAMORE A,MASSARI F,et al.Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers[J].Cancers (Basel),2019,11(9):1225.
[19] GUPTA S.Obesity:The fat advantage[J].Nature,2016,537(7620):S100-S102.
[20] CHEN PZ,HOU XH,HU G,et al.Abdominal subcutaneous adipose tissue:a favorable adipose depot for diabetes[J].Cardiovasc Diabetol,2018,17(1):93.
[21] 王佳妮,张洁,杨大为,等.自身免疫性胰腺炎假包膜CT及MRI表现[J].中国医学影像技术,2021,37(9):1358-1362.
WANG JN,ZHANG J,YANG DW,et al.CT and MRI manifestations of pseudocapsule of autoimmune pancreatitis[J].Chinese Journal of Medical Imaging Technology,2021,37(9):1358-1362.
[22] XV YJ,LV FJ,GUO HM,et al.A CT-based radiomics nomogram integrated with clinic-radiological features for preoperatively predicting WHO/ISUP grade of clear cell renal cell carcinoma[J].Front Oncol,2021,11:712554.